RT Journal Article
SR Electronic
T1 Impact of Superspreaders on dissemination and mitigation of COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.17.20104745
DO 10.1101/2020.05.17.20104745
A1 Sneppen, Kim
A1 Simonsen, Lone
YR 2020
UL http://medrxiv.org/content/early/2020/05/28/2020.05.17.20104745.abstract
AB Background The severity of the Covid-19 pandemic has led to the use of extreme control measures which has halted the spread, but at enormous socioeconomic cost. We set out to explore whether a model that includes ‘superspreader’ could explain aspects of mitigation strategies that explain the dramatic effect.Methods We developed an age structured agent-based model that includes persons who spread the disease far more widely than others, acting in a society in which transmission occurs in three sectors: home, school/work and a third category representing other social contacts. We employ the model to study the impact of lock-down when superspreaders are present.Findings As expected, without mitigation imposed, the inclusion of superspreaders in the population does not change the epidemic trajectory. However in a structured society we find that superspreaders made a substantial difference. Our simulations demonstrate that workplaces and schools may open without much effect on the epidemic, as long as the other social contacts are drastically limited.Interpretation The recent observations of profound pandemic control that cannot be captured by standard SEIR models, require disease transmission models that consider superspreaders. We have found that transmission can be controlled simply by limiting contacts such as public transportation and large events. Indeed, eliminating superspreader opportunities can uniquely explain the success of Sweden’s relaxed approach and the moderate lockdown used in Denmark.Funding KS received funding from the EU Horizon 2020 research program under ERC grant No. 740704, and LS from the Carlsberg Foundation in Denmark.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program under grant agreement No. 740704, and from the Carlsberg Foundation in Denmark.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB body involved here. It is a theoretical paper using publically available data from Danish, Norwegian and Swedish health authorities.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo data.